Related Articles
Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificity
Antitumoral effect of PLK-1-inhibitor BI2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck
Effects of the Polo-like-kinase-1-inhibitor BI2536 in squamous cell carcinoma cell lines of the head and neck
Fighting cancer from different signalling pathways: Effects of the proteasome inhibitor Bortezomib in combination with the polo-like-kinase-1-inhibitor BI2536 in SCCHN
Small molecules in combination with conventional chemotherapeutic drugs: Light at the end of the tunnel?